Medicinal Cannabis Market and Factors Behind its Growing Landscape – Industry Analysis by Top Vendors, Size, Growth Factors and Forecast to 2027 | BOL Pharma, Tilray, Medreleaf Corporation

Medicinal cannabis is also known as medical marijuana which is used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions, and applications such as pain management, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures. Various countries around the globe are involved in legalization of export of medicinal cannabis products, which is expected to fuel growth of the medicinal cannabis market. For instance, in January 2018, the government of Australia allowed cannabis producers in the country to export medicinal cannabis and cannabis products in the global market.

Medicinal Cannabis Market - Competitive Landscape

Key Players: Some of the key players operating in medicinal cannabis market include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc., and Medical Marijuana Inc.

Get PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/40

The Medicinal cannabis market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. Coherent Market Insights Research’s latest publication, titled Medicinal cannabis market, offers an insightful take on the drivers and restraints present in the market. It assesses the historical data pertaining to the Medicinal cannabis market and compares it to the current market trends to give the readers a detailed analysis of the trajectory of the market. A team subject-matter experts have provided the readers a qualitative and quantitative data about the market and the various elements associated with it.

Market Taxonomy

This report segments the global medicinal cannabis market on the basis of point of sale, active ingredient, and therapeutic application. On the basis of point of sale, the global medicinal cannabis market is classified into dispensaries, online pharmacies, and hospital pharmacies. Active ingredients of medicinal cannabis include tetrahydrocannabinol (THC) and Cannabidiol (CBD). Therapeutic application is categorized into pain, arthritis, neurological disease, and other applications.

Increase in the legalization of medicinal cannabis in various economies is expected to augment the market growth

Increasing approvals for medicinal cannabis products and growing research and development activities in the medicinal cannabis market are expected to support growth of the market. For instance, in March 2017, Germany’s parliament passed a law allowing medicinal use of the cannabis plant by allowing healthcare professionals to prescribe medicinal cannabis products to patients suffering from health issues such as chronic pain, vomiting, and nausea. However, health issues resulting from excessive cannabis consumption such as tachycardia, risk of heart attack, particularly in individuals with existing heart disease or arrhythmias, are expected to restrain growth of the market.

Legalization of medicinal cannabis is expected to grow once conclusive evidence regarding its safety and efficacy is obtained through extensive research. For instance, in 2013, Czech Republic legalized medicinal marijuana for patients suffering from chronic pain, epilepsy, chemotherapy induced side effects, and other severe disease indications. Furthermore, the law allows patients with marijuana prescription to purchase medicinal marijuana from pharmacies. However, cultivation of marijuana in not allowed in the country, and thereby suppliers need to import medicinal cannabis. These factors are expected to contribute to the growth of the medicinal cannabis use in pharmaceutical and biotechnology industry.

Browse Research Report At: https://www.coherentmarketinsights.com/market-insight/medicinal-cannabis-market-40

The research report is broken down into chapters, which are introduced by the executive summary. It’s the introductory part of the chapter, which includes details about global market figures, both historical and estimates. The executive summary also provides a brief about the segments and the reasons for the progress or decline during the forecast period. The insightful research report on the Medicinal cannabis market includes Porter’s five forces analysis and SWOT analysis to understand the factors impacting consumer and supplier behavior.

Following are the segments covered by the report are:

The section of the report highlights the regions that are covered under the Medicinal cannabis market are North America, Europe, China, Japan and India. The regional segment provides the market outlook and the forecast within the context of the Medicinal cannabis market. The potential new entrants are targeting only the high growth areas, which are included in the report.

Regions Covered in the Medicinal cannabis Market:

• The Middle East and Africa (GCC Countries and Egypt)
• North America (the United States, Mexico, and Canada)
• South America (Brazil etc.)
• Europe (Turkey, Germany, Russia UK, Italy, France, etc.)
• Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Highlights of the Report:

• Accurate market size and CAGR forecasts for the period 2020-2026.
• Identification and in-depth assessment of growth opportunities in key segments and regions.
• Detailed company profiling of top players of the Medicinal cannabis market.
• Exhaustive research on innovation and other trends of the Medicinal cannabis market.
• Reliable industry value chain and supply chain analysis.
• Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects.

The scope of the Report:

The report segments the Medicinal cannabis market on the basis of application, type, service, technology, and region. Each chapter under this segmentation allows readers to grasp the nitty-gritties of the market. A magnified look at the segment-based analysis is aimed at giving the readers a closer look at the opportunities and threats in the market. It also address political scenarios that are expected to impact the market in both small and big ways. The report on the Medicinal cannabis market examines changing regulatory scenario to make accurate projections about potential investments. It also evaluates the risk for new entrants and the intensity of the competitive rivalry.

Ask For Discount Before Purchasing This Business Report @ https://www.coherentmarketinsights.com/insight/request-discount/40

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the Medicinal cannabis market

Chapter 2: Evaluating the leading manufacturers of the Medicinal cannabis market which consists of its revenue, sales, and price of the products

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales

Chapter 4: Presenting Medicinal cannabis market by regions, market share and with revenue and sales for the projected period

Chapter 5, 6, 7, 8 and 9 : To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.